PMID- 31530690
OWN - NLM
STAT- MEDLINE
DCOM- 20200917
LR  - 20240426
IS  - 1473-4893 (Electronic)
IS  - 1470-2118 (Print)
IS  - 1470-2118 (Linking)
VI  - 19
IP  - 5
DP  - 2019 Sep
TI  - Management of type 2 diabetes: now and the future.
PG  - 403-405
LID - 10.7861/clinmed.2019-0318 [doi]
AB  - There are about 4.7 million people living with diabetes mellitus in the UK and 
      90% have type 2 diabetes mellitus (T2DM). This burden will only get worse as 
      there are currently about 12.3 million more at risk of T2DM. Moreover, up to 30% 
      of diagnosed patients already have eye, foot, kidney or nerve complications. This 
      impacts the NHS considerably as it spends about  pound10 billion annually on diabetes 
      (80% on complications alone). Atherosclerotic cardiovascular disease (ASCVD), the 
      leading cause of death in diabetes, contributes significantly to this. Therefore, 
      there is significant emphasis on the prevention of T2DM especially in at-risk 
      groups with the setting up of initiatives like the Diabetes Prevention Programme. 
      When prevention fails, it is essential to commence glucose-lowering agents to 
      reduce the burden of disease, prevent associated complications and improve 
      quality of life. A patient-centred approach is required to ensure efficacy of 
      treatment strategies and the presence of co-morbidities such as cardiovascular 
      and renal disease should be considered.
CI  - (c) 2019 Royal College of Physicians.
FAU - Edeghere, Simon
AU  - Edeghere S
AD  - Plymouth Hospitals NHS Trust, Plymouth, UK simon.edeghere@nhs.net.
FAU - English, Patrick
AU  - English P
AD  - Plymouth Hospitals NHS Trust, Plymouth, UK.
LA  - eng
PT  - Journal Article
PL  - England
TA  - Clin Med (Lond)
JT  - Clinical medicine (London, England)
JID - 101092853
RN  - 0 (Hypoglycemic Agents)
SB  - IM
MH  - Diabetes Mellitus, Type 2/*drug therapy
MH  - Humans
MH  - Hypoglycemic Agents/therapeutic use
MH  - Male
MH  - Middle Aged
MH  - *Patient-Centered Care
MH  - Practice Guidelines as Topic
PMC - PMC6771348
OTO - NOTNLM
OT  - Type 2 diabetes mellitus
OT  - cardiovascular disease
OT  - chronic kidney disease
OT  - glucose-lowering agents
OT  - heart failure
EDAT- 2019/09/19 06:00
MHDA- 2020/09/18 06:00
PMCR- 2019/09/01
CRDT- 2019/09/19 06:00
PHST- 2019/09/19 06:00 [entrez]
PHST- 2019/09/19 06:00 [pubmed]
PHST- 2020/09/18 06:00 [medline]
PHST- 2019/09/01 00:00 [pmc-release]
AID - S1470-2118(24)00132-5 [pii]
AID - clinmedicine [pii]
AID - 10.7861/clinmed.2019-0318 [doi]
PST - ppublish
SO  - Clin Med (Lond). 2019 Sep;19(5):403-405. doi: 10.7861/clinmed.2019-0318.